Concepedia

Masaki Yamazaki

MY

16

Publications

527

Citations

13

H-Index

1998

Active since

Affiliations

Chugai Pharma (United States)(Current)

Monash University

The Alfred Hospital

The University of Tokyo

University of Oxford

Masaki Yamazaki is an author at Chugai Pharma (United States) specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

1998–2024

16

Publications

16

LGR5‐Positive Colon Cancer Stem Cells Interconvert with Drug‐Resistant LGR5‐Negative cells and are Capable of Tumor Reconstitution

Shinta Kobayashi, Hisafumi Yamada‐Okabe, Masami Suzuki et al. · Stem Cells · 2012 · 187 citations · Full text

, , +22

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Christiana Kartsonaki, J. Kenneth Baillie, Noelia García Barrio et al. · International Journal of Epidemiology · 2023 · 68 citations · Full text

An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients

Gianluigi Li Bassi, Jacky Y. Suen, Heidi J. Dalton et al. · Critical Care · 2021 · 40 citations · Full text

A simple method for histopathological evaluation of organoids

Etsuko Fujii, Masaki Yamazaki, Shigeto Kawai et al. · Journal of Toxicologic Pathology · 2017 · 33 citations · Full text

Three-dimensional culture models mimic colon cancer heterogeneity induced by different microenvironments

Shigeto Kawai, Masaki Yamazaki, Keita Shibuya et al. · Scientific Reports · 2020 · 30 citations · Full text

Rows per page

1–5 of 16